Objective: To evaluate the effects of continuous oral administration of phenylbutazone on serum and synovial fluid biomarkers of skeletal matrix metabolism in horses.
Animals: 11 adult female horses without clinical or radiographic evidence of joint disease.
Procedures: Horses were randomly assigned to control or treatment groups.